-
Eli Lilly Shares Spike On Patent Victory
Thursday, October 5, 2017 - 5:07pm | 350The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co (NYSE: LLY) Thursday in an inter partes review of the ’209 patent for Alimta, a chemotherapy drug for lung cancer. “Based on the record before us, we conclude that petitioner has failed to demonstrate by a...
-
Teva 'Disappointed' In Court's Patent Decision
Thursday, January 12, 2017 - 11:50am | 170In the latest development in the court battle between Eli Lilly And Co (NYSE: LLY) and Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) over an Alimta patent, the U.S. Court of Appeals ruled that Teva was liable for inducing patent infringement by physicians. This decision supported that...
-
Eli Lilly's Guidance Supported By Short-Term Boosts, Not Better Fundamentals
Friday, December 16, 2016 - 12:22pm | 343Investors appear to be pleased with Eli Lilly and Co (NYSE: LLY)'s business after the company updated the investment community with short- and longer-term guidance. Eli Lilly's stock gained more than 5 percent on Thursday and was trading higher by another 1.50 percent at $72.45 ahead of Friday's...
-
Goldman Confident In Merck's Keytruda
Tuesday, June 7, 2016 - 2:43pm | 288Goldman Sachs said evidence of Merck & Co., Inc. (NYSE: MRK)'s Keytruda benefit as a single agent continues to build as registrational monotherapy studies read out. Merck's data presented at ASCO (American Society of Clinical Oncology) include updates on new tumors, existing tumors and...
-
Market Wrap For April 1: S&P 500 Hitting New All-Time High Not An April Fools' Joke
Tuesday, April 1, 2014 - 4:47pm | 1704U.S. stocks kicked off a new month and new quarter with solid gains as U.S. manufacturing growth improved in March. The indexes have now logged a three-day winning streak, an accomplishment which was completely absent throughout all of March. The S&P 500 hit new all-time highs of 1,885.84...